Coxsackie B vaccine shows good safety and immunogenicity in a Phase I trial

An important milestone reached in the development of coxsackie B vaccine. Results of phase 1 human trial showed good safety and immunogenicity.

Read the whole article here: https://doi.org/10.1007/s00125-024-06092-w